Table of Content

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
TABLE 1 INCLUSIONS & EXCLUSIONS 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 STAKEHOLDERS 21
1.6 SUMMARY OF CHANGES 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
FIGURE 1 RESEARCH DESIGN 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Secondary sources 24
2.1.2 PRIMARY DATA 25
FIGURE 2 BREAKDOWN OF PRIMARIES: HUMAN ORGANOIDS MARKET 25
2.2 MARKET ESTIMATION METHODOLOGY 26
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 26
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 27
2.2.2 PROCEDURE-BASED MARKET ESTIMATION 27
FIGURE 4 MARKET SIZE ESTIMATION: HUMAN ORGANOIDS MARKET 28
2.2.3 PRIMARY RESEARCH VALIDATION 28
2.3 DATA TRIANGULATION 29
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
2.4 RESEARCH ASSUMPTIONS 30
2.5 RESEARCH LIMITATIONS 30

3 EXECUTIVE SUMMARY 31
FIGURE 6 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 31
FIGURE 7 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 32
FIGURE 8 HUMAN ORGANOIDS MARKET SHARE, BY END USER, 2020 VS. 2025 32
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE HUMAN ORGANOIDS MARKET 33
_

4 PREMIUM INSIGHTS 34
4.1 HUMAN ORGANOIDS MARKET OVERVIEW 34
FIGURE 10 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING MODELS TO DRIVE MARKET GROWTH 34
4.2 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 35
FIGURE 11 LIVER ORGANOIDS ARE EXPECTED TO DOMINATE THE HUMAN ORGANOID PRODUCTS MARKET 35
4.3 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER & COUNTRY (2019) 36
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC HUMAN ORGANOIDS MARKET IN 2019 36
4.4 GEOGRAPHIC ANALYSIS: HUMAN ORGANOIDS MARKET, BY USABILITY (2019) 37
FIGURE 13 READY-TO-USE PRODUCTS SEGMENT DOMINATES THE GLOBAL HUMAN ORGANOIDS MARKET 37
4.5 HUMAN ORGANOIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
FIGURE 15 HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
& CHALLENGES 38
5.2.1 DRIVERS 39
5.2.1.1 Growing focus on developing alternatives for animal testing models 39
5.2.1.2 Significant increase in research funding and venture capital investments for the development of human organoids 39
5.2.1.3 Growing initiatives to increase awareness about organoids 40
TABLE 2 GROWING INITIATIVES AND EVENTS FOR ORGANOIDS 40
5.2.1.4 Increasing research activities on organoids 41
TABLE 3 RESEARCH PROJECTS AND ACTIVITIES 41
5.2.1.5 Increasing prevalence of non-alcoholic fatty liver disease 42
5.2.1.6 Growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure 42
5.2.2 RESTRAINTS 43
5.2.2.1 Issues related to the incorporation of organoids into existing workflows 43
5.2.3 OPPORTUNITIES 43
5.2.3.1 Increasing focus on drug discovery activities 43
5.2.3.2 Rising demand for organ transplantation 43
5.2.3.3 Growing healthcare market in the Asia Pacific and Latin America 44
5.2.4 CHALLENGES 45
5.2.4.1 Dearth of skilled professionals 45
_
5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE HUMAN ORGANOIDS MARKET 45
5.4 REGULATORY SCENARIO 46
5.5 ECOSYSTEM COVERAGE 47
5.6 TECHNOLOGY ANALYSIS 48
5.7 PRICING ANALYSIS 48

6 HUMAN ORGANOIDS MARKET, BY PRODUCT 49
6.1 INTRODUCTION 50
TABLE 4 HUMAN ORGANOIDS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 50
6.2 LIVER 50
TABLE 5 HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION) 50
6.2.1 2D LIVER MODELS 51
TABLE 6 2D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 51
6.2.1.1 Fresh hepatocytes 51
TABLE 7 FRESH HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION) 52
6.2.1.2 Cryopreserved hepatocytes 52
TABLE 8 CRYOPRESERVED HEPATOCYTES MARKET, BY REGION,
2018-2025 (USD MILLION) 52
6.2.1.3 Other 2D liver models 53
TABLE 9 OTHER 2D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 53
6.2.2 3D LIVER MODELS 53
TABLE 10 3D LIVER MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 54
TABLE 11 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 54
6.2.2.1 Liver organoids 55
TABLE 12 LIVER ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 55
6.2.2.2 3D bioprinted liver 56
TABLE 13 3D BIOPRINTED LIVER MARKET, BY REGION, 2018-2025 (USD MILLION) 56
6.2.2.3 Spheroids 57
TABLE 14 LIVER SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 57
6.2.2.4 Liver-on-a-chip 57
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2018-2025 (USD MILLION) 58
6.2.2.5 Other 3D liver models 59
TABLE 16 OTHER 3D LIVER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 59
6.3 KIDNEY 59
TABLE 17 HUMAN KIDNEY ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION) 59
6.3.1 2D KIDNEY MODELS 60
TABLE 18 2D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 60
6.3.1.1 Fresh kidney cells 60
TABLE 19 FRESH KIDNEY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 60
6.3.1.2 Cryopreserved cells 61
TABLE 20 KIDNEY CRYOPRESERVED CELLS MARKET, BY REGION,
2018-2025 (USD MILLION) 61
6.3.1.3 Other 2D kidney models 61
TABLE 21 OTHER 2D KIDNEY MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 62
6.3.2 3D KIDNEY MODELS 62
TABLE 22 3D KIDNEY MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 62
TABLE 23 3D KIDNEY MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 63
6.3.2.1 Organoids 63
TABLE 24 KIDNEY ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 63
6.3.2.2 3D bioprinted kidney 64
TABLE 25 3D BIOPRINTED KIDNEY MARKET, BY REGION, 2018-2025 (USD MILLION) 64
6.3.2.3 Spheroids 64
TABLE 26 KIDNEY SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 65
6.3.2.4 Other 3D kidney models 65
TABLE 27 OTHER 3D KIDNEY MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 65
6.4 PANCREAS 66
TABLE 28 HUMAN PANCREAS ORGANOIDS MARKET, BY TYPE,
2018-2025 (USD MILLION) 66
6.4.1 2D PANCREATIC MODELS 66
TABLE 29 2D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 66
6.4.1.1 Cryopreserved cells 67
TABLE 30 PANCREATIC CRYOPRESERVED CELLS MARKET, BY REGION,
2018-2025 (USD MILLION) 67
6.4.1.2 Fresh cells 67
TABLE 31 PANCRATIC FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 68
6.4.1.3 Other 2D pancreatic models 68
TABLE 32 OTHER 2D PANCREATIC MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 68
6.4.2 3D PANCREATIC MODELS 69
TABLE 33 3D PANCREATIC MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 69
TABLE 34 3D PANCREATIC MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 69
6.4.2.1 Organoids 70
TABLE 35 PANCREATIC ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 70
6.4.2.2 3D bioprinted pancreas 70
TABLE 36 3D BIOPRINTED PANCREAS MARKET, BY REGION,
2018-2025 (USD MILLION) 70
6.4.2.3 Spheroids 71
TABLE 37 PANCREATIC SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 71
6.4.2.4 Other 3D pancreatic models 71
TABLE 38 OTHER 3D PANCREATIC MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 71
6.5 COLORECTAL 72
TABLE 39 HUMAN COLORECTAL ORGANOIDS MARKET, BY TYPE,
2018-2025 (USD MILLION) 72
6.5.1 2D COLORECTAL MODELS 72
TABLE 40 2D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 72
6.5.1.1 Fresh cells 73
TABLE 41 COLORECTAL FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 73
6.5.1.2 Cryopreserved cells 73
TABLE 42 COLORECTAL CRYOPRESERVED CELLS MARKET, BY REGION,
2018-2025 (USD MILLION) 73
6.5.1.3 Other 2D colorectal models 74
TABLE 43 OTHER 2D COLORECTAL MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 74
6.5.2 3D COLORECTAL MODELS 74
TABLE 44 3D COLORECTAL MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 74
TABLE 45 3D COLORECTAL MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 75
6.5.2.1 Organoids 75
TABLE 46 COLORECTAL ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 75
6.5.2.2 3D bioprinted models 76
TABLE 47 COLORECTAL 3D BIOPRINTED MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 76
6.5.2.3 Spheroids 76
TABLE 48 COLORECTAL SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 76
6.5.2.4 Other 3D colorectal models 77
TABLE 49 OTHER 3D COLORECTAL MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 77
6.6 HEART 77
TABLE 50 HUMAN HEART ORGANOIDS MARKET, BY TYPE, 2018-2025 (USD MILLION) 77
6.6.1 2D HEART MODELS 78
TABLE 51 2D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 78
6.6.1.1 Fresh cells 78
TABLE 52 HEART FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 78
6.6.1.2 Cryopreserved cells 79
TABLE 53 HEART CRYOPRESERVED CELLS MARKET, BY REGION,
2018-2025 (USD MILLION) 79
6.6.1.3 Other 2D heart models 79
TABLE 54 OTHER 2D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 79
6.6.2 3D HEART MODELS 80
TABLE 55 3D HEART MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 80
TABLE 56 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 80
6.6.2.1 Organoids 81
TABLE 57 HEART ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 81
6.6.2.2 3D bioprinted heart 81
TABLE 58 3D BIOPRINTED HEART MARKET, BY REGION, 2018-2025 (USD MILLION) 82
6.6.2.3 Spheroids 82
TABLE 59 HEART SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 82
6.6.2.4 Other 3D heart models 83
TABLE 60 OTHER 3D HEART MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 83
6.7 OTHER PRODUCTS 83
TABLE 61 HUMAN ORGANOIDS MARKET FOR OTHER PRODUCTS, BY TYPE,
2018-2025 (USD MILLION) 83
6.7.1 2D MODELS 84
TABLE 62 OTHERS 2D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 84
6.7.1.1 Fresh cells 84
TABLE 63 OTHERS FRESH CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 84
6.7.1.2 Cryopreserved cells 85
TABLE 64 OTHERS CRYOPRESERVED CELLS MARKET, BY REGION,
2018-2025 (USD MILLION) 85
6.7.1.3 Other 2D models 85
TABLE 65 OTHERS OTHER 2D MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 85
6.7.2 3D MODELS 86
TABLE 66 OTHERS 3D MODELS MARKET, BY TYPE, 2018-2025 (USD MILLION) 86
TABLE 67 3D OTHER MODELS MARKET, BY REGION, 2018-2025 (USD MILLION) 86
6.7.2.1 Organoids 87
TABLE 68 OTHERS ORGANOIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 87
6.7.2.2 3D bioprinted models 87
TABLE 69 OTHERS 3D BIOPRINTED MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 88
6.7.2.3 Spheroids 88
TABLE 70 OTHERS SPHEROIDS MARKET, BY REGION, 2018-2025 (USD MILLION) 88
6.7.2.4 Other 3D models 89
TABLE 71 OTHERS OTHER 3D MODELS MARKET, BY REGION,
2018-2025 (USD MILLION) 89

7 HUMAN ORGANOIDS MARKET, BY USABILITY 90
7.1 INTRODUCTION 91
TABLE 72 HUMAN ORGANOIDS MARKET, BY USABILITY, 2018-2025 (USD MILLION) 91
7.2 READY-TO-USE PRODUCTS 91
7.2.1 READY-TO-USE PRODUCTS SEGMENT TO DOMINATE THE MARKET AS THEY CAN BE MASS PRODUCED 91
TABLE 73 HUMAN ORGANOIDS MARKET FOR READY-TO-USE PRODUCTS, BY REGION, 2018-2025 (USD MILLION) 92
7.3 CUSTOMIZABLE PRODUCTS 92
7.3.1 CUSTOMIZABLE PRODUCTS CAN FULFIL THE REQUIREMENT FOR A SPECIFIC NEED OF ORGAN TRANSPLANTATION 92
TABLE 74 HUMAN ORGANOIDS MARKET FOR CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2025 (USD MILLION) 93
_

8 HUMAN ORGANOIDS MARKET, BY APPLICATION 94
8.1 INTRODUCTION 95
TABLE 75 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 95
8.2 DEVELOPMENTAL BIOLOGY 96
8.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF 3D BIOPRINTING WILL BOOST MARKET GROWTH 96
TABLE 76 HUMAN ORGANOIDS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2025 (USD MILLION) 96
8.3 DRUG TOXICITY & EFFICACY TESTING 97
8.3.1 DRUG TOXICITY & EFFICACY TESTING WILL WITNESS GROWTH AS ORGANOIDS SHOW HIGH RESISTANCE TOWARDS CLINICAL DOSES 97
TABLE 77 HUMAN ORGANOIDS MARKET FOR DRUG TOXICITY & EFFICACY TESTING,
BY REGION, 2018-2025 (USD MILLION) 97
8.4 DISEASE PATHOLOGY 98
8.4.1 DEVELOPMENT OF INTESTINAL ORGANOIDS TO SUPPORT MARKET GROWTH 98
TABLE 78 HUMAN ORGANOIDS MARKET FOR DISEASE PATHOLOGY, BY REGION,
2018-2025 (USD MILLION) 98
8.5 PERSONALIZED MEDICINE 99
8.5.1 HIGH COST OF DEVELOPING ORGANOIDS TO HAMPER MARKET GROWTH 99
TABLE 79 HUMAN ORGANOIDS MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018-2025 (USD MILLION) 99
8.6 REGENERATIVE MEDICINE 100
8.6.1 ORGANOIDS HOLD A HUGE POTENTIAL IN REGENERATIVE MEDICINE PURPOSES 100
TABLE 80 HUMAN ORGANOIDS MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2018-2025 (USD MILLION) 100
8.7 OTHER APPLICATIONS 101
TABLE 81 HUMAN ORGANOIDS MARKET FOR OTHER APPLICATIONS, BY REGION,
2018-2025 (USD MILLION) 101

9 HUMAN ORGANOIDS MARKET, BY END USER 102
9.1 INTRODUCTION 103
TABLE 82 HUMAN ORGANOIDS MARKET, BY END USER, 2018-2025 (USD MILLION) 103
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 103
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF HUMAN ORGANOID PRODUCTS 103
TABLE 83 HUMAN ORGANOIDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION) 104
9.3 CONTRACT RESEARCH ORGANIZATIONS 104
9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH SERVICES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH 104
TABLE 84 HUMAN ORGANOIDS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION) 105
_
9.4 ACADEMIC & RESEARCH INSTITUTES 105
9.4.1 HIGH COST OF TECHNOLOGICALLY ADVANCED ORGANOIDS IS EXPECTED TO HAMPER MARKET GROWTH FOR THESE FACILITIES 105
TABLE 85 HUMAN ORGANOIDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2018-2025 (USD MILLION) 106
9.5 OTHER END USERS 106
TABLE 86 HUMAN ORGANOIDS MARKET FOR OTHER END USERS, BY REGION,
2018-2025 (USD MILLION) 106

10 HUMAN ORGANOIDS MARKET, BY REGION 107
10.1 INTRODUCTION 108
TABLE 87 HUMAN ORGANOIDS MARKET, BY REGION, 2018–2025 (USD MILLION) 108
10.2 NORTH AMERICA 108
FIGURE 16 NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT 109
TABLE 88 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 109
TABLE 89 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 90 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 91 NORTH AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 92 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 111
TABLE 93 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY,
2018–2025 (USD MILLION) 111
TABLE 94 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY END USER,
2018–2025 (USD MILLION) 111
10.2.1 US 112
10.2.1.1 Ongoing technological advancements in the field of transplantation to drive market growth in the US 112
TABLE 95 US: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
10.2.2 CANADA 112
10.2.2.1 Growing availability of human organoid products to support market growth in Canada 112
TABLE 96 CANADA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
10.3 EUROPE 113
TABLE 97 EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 114
TABLE 98 EUROPE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 114
TABLE 99 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION) 114
TABLE 100 EUROPE: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 101 EUROPE: HUMAN ORGANOIDS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 115
TABLE 102 EUROPE: HUMAN ORGANOIDS MARKET, BY USABILITY,
2018–2025 (USD MILLION) 115
TABLE 103 EUROPE: HUMAN ORGANOIDS MARKET, BY END USER,
2018–2025 (USD MILLION) 116
10.3.1 GERMANY 116
10.3.1.1 Germany dominates the European human organoids market 116
TABLE 104 GERMANY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
10.3.2 UK 117
10.3.2.1 Rising number of transplantation procedures to drive market growth in the UK 117
TABLE 105 UK: NUMBER OF TRANSPLANTATION PROCEDURES, BY ORGAN TYPE, 2018 117
TABLE 106 UK: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
10.3.3 FRANCE 118
10.3.3.1 Adoption of molecular diagnostic techniques for donor-recipient compatibility testing is increasing in France 118
TABLE 107 FRANCE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
10.3.4 ITALY 119
10.3.4.1 Sluggish growth in the Italian healthcare sector to restrain the market growth 119
TABLE 108 ITALY: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
10.3.5 SPAIN 119
10.3.5.1 Rising number of solid organ transplantation procedures to drive market growth in Spain 119
TABLE 109 SPAIN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
10.3.6 REST OF EUROPE 120
TABLE 110 ROE: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
10.4 ASIA PACIFIC 121
FIGURE 17 ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT 121
TABLE 111 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 122
TABLE 112 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 113 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 114 ASIA PACIFIC: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 115 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 123
TABLE 116 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY USABILITY,
2018–2025 (USD MILLION) 123
TABLE 117 ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY END USER,
2018–2025 (USD MILLION) 124
10.4.1 JAPAN 124
10.4.1.1 Growth in biomedical & medical research to support market growth 124
TABLE 118 JAPAN: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
10.4.2 CHINA 125
10.4.2.1 Healthcare infrastructure improvements to support market growth in China 125
TABLE 119 CHINA: NUMBER OF ORGAN TRANSPLANTATION PROCEDURES PERFORMED, 2018 125
TABLE 120 CHINA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
10.4.3 INDIA 127
10.4.3.1 Increasing number of transplantation procedures to drive market growth in India 127
TABLE 121 INDIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
10.4.4 AUSTRALIA 127
10.4.4.1 Rising number of solid organ transplantation procedures to support market growth in Australia 127
TABLE 122 AUSTRALIA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
10.4.5 SOUTH KOREA 128
10.4.5.1 Government initiatives to introduce medical coverage for transplantation to support market growth in South Korea 128
TABLE 123 SOUTH KOREA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
10.4.6 REST OF ASIA PACIFIC 128
TABLE 124 ROAPAC: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
10.5 LATIN AMERICA 129
TABLE 125 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 130
TABLE 126 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 127 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 128 LATIN AMERICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS,
BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 129 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 131
TABLE 130 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY USABILITY,
2018–2025 (USD MILLION) 131
TABLE 131 LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY END USER,
2018–2025 (USD MILLION) 132
10.5.1 BRAZIL 132
10.5.1.1 Brazil is the largest market for human organoids in Latin America 132
TABLE 132 BRAZIL: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
10.5.2 MEXICO 133
10.5.2.1 Rising medical tourism to support market growth in Mexico 133
TABLE 133 MEXICO: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
10.5.3 REST OF LATIN AMERICA 133
TABLE 134 ROLATAM: HUMAN LIVER ORGANOIDS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
10.6 MIDDLE EAST & AFRICA 134
10.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH 134
TABLE 135 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET, BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 136 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 2D MODELS, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 137 MIDDLE EAST & AFRICA: HUMAN LIVER ORGANOIDS MARKET FOR 3D MODELS, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 138 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 135
TABLE 139 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY USABILITY, 2018–2025 (USD MILLION) 136
TABLE 140 MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY END USER, 2018–2025 (USD MILLION) 136

11 COMPETITIVE LANDSCAPE 137
11.1 OVERVIEW 137
FIGURE 18 KEY DEVELOPMENTS IN THE HUMAN ORGANOIDS MARKET, 2017–2020 137
11.2 MARKET SHARE ANALYSIS 138
FIGURE 19 HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2019 138
11.3 COMPETITIVE SCENARIO 139
11.3.1 PRODUCT LAUNCHES 139
TABLE 141 PRODUCT LAUNCH, 2017-2020 139
11.3.2 AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS 139
TABLE 142 AGREEMENTS, COLLABORATIONS & PARTNERSHIP, 2017-2020 139
11.3.3 MERGERS 140
TABLE 143 MERGERS, 2018 140

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 141
12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY 141
12.1.1 STARS 141
12.1.2 EMERGING LEADERS 141
12.1.3 PERVASIVE 141
12.1.4 PARTICIPANTS 141
FIGURE 20 HUMAN ORGANOIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 142
_
12.2 COMPANY PROFILES 143
(Business overview, Products offered & Recent developments)*
12.2.1 BIOIVT 143
12.2.2 CELLINK 147
FIGURE 21 CELLINK: COMPANY SNAPSHOT 147
12.2.3 CORNING INCORPORATED 148
FIGURE 22 CORNING INCORPORATED: COMPANY SNAPSHOT 148
12.2.4 CYTES BIOTECHNOLOGIES, S.L. 150
12.2.5 H?REL CORPORATION 151
12.2.6 INSPHERO 152
12.2.7 KALY-CELL 153
12.2.8 KIRKSTALL LTD. 154
12.2.9 MIMETAS B.V. 155
12.2.10 NEUROMICS 156
12.2.11 ORGANOVO 157
12.2.12 PRIMACYT CELL CULTURE TECHNOLOGY GMBH 158
12.2.13 STEMCELL TECHNOLOGIES INC. 159
12.2.14 THERMO FISHER SCIENTIFIC 160
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 160
12.2.15 ZENBIO, INC. 162
*Details on Business overview, Products offered & Recent developments might not be captured in case of unlisted companies.
12.3 EMERGING COMPANIES 163
12.3.1 BIOPREDIC INTERNATIONAL 163
12.3.2 CN BIO INNOVATIONS 163
12.3.3 CYPRIO 164
12.3.4 EMULATE, INC. 164
12.3.5 KERAFAST 165

13 APPENDIX 166
13.1 DISCUSSION GUIDE 166
13.3 AVAILABLE CUSTOMIZATIONS 173
13.4 RELATED REPORTS 173
13.5 AUTHOR DETAILS 174